NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME

• 收藏
• 分享

专利权人:

The Children's Hospital of Philadelphia

发明人:

Hakon Hakonarson,Charlly Kao

申请号：

US15850307

公开号：

US20180110767A1

申请日:

2017.12.21

申请国别(地区):

US

年份:

2018

代理人:

摘要：

This application relates to methods of treating attention deficit hyperactivity disorder (ADHD), 22q deletion and/or duplication syndrome, and co-morbidities with a nonselective activator of metabotropic glutamate receptors, such as fasoracetam, for example, in subjects having a genetic alteration in at least one metabotropic glutamate receptor (mGluR) network gene.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/